FITC Mouse Anti-Human HLA-DR Antibody (S-R566)

產(chǎn)品型號(hào)：S0B1755

更新時(shí)間：2025-10-08

廠商性質(zhì)：生產(chǎn)廠家

訪問(wèn)量：93

服務(wù)熱線

15855403091

立即咨詢(xún)

產(chǎn)品分類(lèi)

PRODUCT CLASSIFICATION

抗體/抗原

ELISA試劑盒抗體試劑盒二抗試劑盒二抗其它流式抗體瓊脂糖/磁珠偶聯(lián)抗體抗Payload抗體泛修飾抗體標(biāo)簽/內(nèi)參抗體功能性抗體 Biosimilar抗體偶聯(lián)抗體配對(duì)抗體病理/IHC抗體

查看全部產(chǎn)品

相關(guān)文章

uPAR/CD87：腫瘤微環(huán)境中的“多面手”

從實(shí)驗(yàn)室到臨床：蛋白激酶藥物的輝煌20年

功能性抗體：如何解鎖其在生物醫(yī)學(xué)研究中的無(wú)限潛能？

致癌分子的失控狂飆：EGFR 信號(hào)通路如何驅(qū)動(dòng)腫瘤生長(zhǎng)？

產(chǎn)品介紹

HLA-DR is a class II Major Histocompatibility Complex （MHC） antigen in human. It is primarily expressed on immune cells, especially dendritic cells and macrophages, and plays a crucial role in recognizing and distinguishing foreign substances from self-tissues. It is involved in regulating the activation status of these cells and plays a key role in immune responses, including anti-infection immunity, tumor immunity, and transplantation immunity. In organ transplantation, HLA-DR is closely related to organ transplant rejection reactions. In the fields of hematopoietic stem cell transplantation and bone marrow transplantation, HLA-DR also plays an important role. Changes in the expression level of HLA-DR are related to the diagnosis of inflammatory diseases, the assessment of severity, and the monitoring of immune status. Unlike other cell activation markers such as CD69, CD25, and CD38, HLA-DR is not expressed on most T cells and is only expressed on a subset of activated T cells during the late stages of an immune response.

上一個(gè)：S0B1218Rat Anti-Mouse/Human CD11b Antibody(S-R574)